Published Online
on February 11, 2008

A more recent version of this article appeared on February 26, 2008

This Article Full Text (PDF) Data Supplement All Versions of this Article: 117/8/1055    most recent CIRCULATIONAHA.107.749234v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Salio, M. Articles by Mantovani, A. Search for Related Content PubMed PubMed Citation Articles by Salio, M. Articles by Mantovani, A. Related Collections Animal models of human disease Genetically altered mice Acute myocardial infarction Related Article

Submitted on October 30, 2008
Accepted on December 14, 2008

Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction

Monica Salio PharmD, Stefano Chimenti PharmD, Noeleen De Angelis BiolD, Fabiola Molla BiolD, Virginia Maina BiolD, Manuela Nebuloni MD, Fabio Pasqualini BS, Roberto Latini MD, Cecilia Garlanda VetScD, and Alberto Mantovani MD^*

From the Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy (M.S., S.C., N.D.A., F.M., R.L.); Istituto Clinico Humanitas, IRCCS, Rozzano, Italy (V.M., F.P., C.G., A.M.); Pathology Unit, "L. Sacco" Department of Clinical Sciences (M.N.) and Institute of General Pathology (A.M.), University of Milan, Milan, Italy; and Department of Medicine, New York Medical College, Valhalla (R.L.).

^* To whom correspondence should be addressed. E-mail: alberto.mantovani{at}humanitas.it.

Background—Despite widespread clinical use as a prognostic marker in ischemic heart disorders, the actual pathogenetic role of the short pentraxin, C-reactive protein, has not undergone stringent genetic testing because of evolutionary divergence between mouse and humans. The long pentraxin PTX3 is conserved in evolution, is expressed in the heart under inflammatory conditions, and is a candidate prognostic marker in acute myocardial infarction. It was therefore important to assess whether PTX3 plays a pathogenetic role in acute myocardial infarction.

Methods and Results—In a model of acute myocardial infarction caused by coronary artery ligation and reperfusion, tissue mRNA expression and circulating levels of PTX3 increased. The interleukin-1R–MyD88 pathway plays a pivotal role in the induction of PTX3 transcript after ischemia. ptx3-deficient mice showed exacerbated heart damage (33% larger infarcts in null mice; P=0.0047). Increased myocardial damage in ptx3-deficient mice was associated with a greater no-reflow area, increased neutrophil infiltration, decreased number of capillaries, and increased number of apoptotic cardiomyocytes. In addition, ptx3-deficient mice with acute myocardial infarction showed higher circulating levels of interleukin-6 and increased C3 deposition in lesional tissue. The phenotype was reversed by exogenous PTX3.

Conclusions—Thus, PTX3 plays a nonredundant, regulatory, cardioprotective role in acute myocardial infarction in mice. Our results suggest that modulation of the complement cascade contributes to the cardioprotective function of PTX3.

Key words: heart diseases • infarction • inflammation • ischemia • reperfusion

Related Article:

Clinical Summaries
Circulation 2008 117: 987-989. [Extract] [Full Text]

This article has been cited by other articles:

				Z. Cao, Y. Hu, W. Wu, T. Ha, J. Kelley, C. Deng, Q. Chen, C. Li, J. Li, and Y. Li The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury Cardiovasc Res, December 1, 2009; 84(3): 442 - 451. [Abstract] [Full Text] [PDF]

				A. Mantovani, C. Garlanda, and M. Locati Macrophage Diversity and Polarization in Atherosclerosis: A Question of Balance Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1419 - 1423. [Abstract] [Full Text] [PDF]

				G. D. Norata, P. Marchesi, V. K. Pulakazhi Venu, F. Pasqualini, A. Anselmo, F. Moalli, I. Pizzitola, C. Garlanda, A. Mantovani, and A. L. Catapano Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis Circulation, August 25, 2009; 120(8): 699 - 708. [Abstract] [Full Text] [PDF]

				V. Maina, A. Cotena, A. Doni, M. Nebuloni, F. Pasqualini, C. M. Milner, A. J. Day, A. Mantovani, and C. Garlanda Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6 J. Leukoc. Biol., July 1, 2009; 86(1): 123 - 132. [Abstract] [Full Text] [PDF]

				D. G. Souza, F. A. Amaral, C. T. Fagundes, F. M. Coelho, R. M.E. Arantes, L. P. Sousa, M. M. Matzuk, C. Garlanda, A. Mantovani, A. A. Dias, et al. The Long Pentraxin PTX3 Is Crucial for Tissue Inflammation after Intestinal Ischemia and Reperfusion in Mice Am. J. Pathol., April 1, 2009; 174(4): 1309 - 1318. [Abstract] [Full Text] [PDF]

				S. Heymans, E. Hirsch, S. D. Anker, P. Aukrust, J.-L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, February 1, 2009; 11(2): 119 - 129. [Abstract] [Full Text] [PDF]

				L. Deban, H. Jarva, M. J. Lehtinen, B. Bottazzi, A. Bastone, A. Doni, T. S. Jokiranta, A. Mantovani, and S. Meri Binding of the Long Pentraxin PTX3 to Factor H: Interacting Domains and Function in the Regulation of Complement Activation J. Immunol., December 15, 2008; 181(12): 8433 - 8440. [Abstract] [Full Text] [PDF]

				A. Doni, G. Mantovani, C. Porta, J. Tuckermann, H. M. Reichardt, A. Kleiman, M. Sironi, L. Rubino, F. Pasqualini, M. Nebuloni, et al. Cell-specific Regulation of PTX3 by Glucocorticoid Hormones in Hematopoietic and Nonhematopoietic Cells J. Biol. Chem., October 31, 2008; 283(44): 29983 - 29992. [Abstract] [Full Text] [PDF]